Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders

Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders

US Patent 6569853 · Granted May 27, 2003

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

NT5C2 inhibitors for the treatment of chemotherapy-resistant acute lymphoblastic2025
Substituted pyrrolo[2,3-b]pyridines for suppressing toxic endoplasmic reticulum 2025
Pyridinone- and pyridazinone-based compounds and uses thereof2024
Macrocyclic compounds as proteasome inhibitors2023
Peptidomimetic proteasome inhibitors2023
CRISPR-related methods and compositions with governing gRNAS2022
Peptidomimetic proteasome inhibitors2021
Compounds, compositions, and methods for modulating ferroptosis and treating exc2021
Tetrahydronaphthyridinepentanamide integrin antagonists2021
Pyrazoloquinazolinone antitumor agents2021
Polypeptides which bind C-X-C chemokine receptor type 4 (CXCR4) and methods of t2021
Amyloid beta oligomer specific binding molecule2021